With Actos ads, Takeda looks to distance drug from Avandia

Matthew Arnold

November 16 2007

Days after FDA ordered a second black-box warning for GlaxoSmithKline's controversial diabetes drug Avandia, Takeda is looking to capitalize on ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.